Orionis Biosciences
Irma Lemmens has extensive work experience in the field of biosciences and medical sciences. Irma is currently working as a Senior Scientist at Orionis Biosciences since May 2020. Prior to that, they worked as a Senior post-doc at Ghent University from October 2000 to May 2020. Irma also has experience as a PhD student in Medical Sciences at the University of Leuven from October 1995 to September 2000.
Irma Lemmens has a strong educational background in the field of science. Irma obtained their Master of Science degree in Biochemistry and Molecular Biology from Radboud University, where they studied from 1990 to 1995. Following their master's degree, Irma pursued further education at the University of Leuven, earning a PhD in Medical Sciences. Irma attended the University of Leuven from 1995 to 2000 to complete their doctoral studies.
This person is not in any offices
Orionis Biosciences
1 followers
Orionis Biosciences operates in the healthcare industry focusing on the biotechnology business and innovation.The company is an early-stage drug discovery and development biotechnology company fueled by a suite of disruptive technologies to advance innovative medicines for the treatment of diseases with high unmet medical needs – with an initialinternal focus in oncology and immunotherapies.Orionis Biosciences has research facilities in the Boston area (Headquarters in Waltham, MA, USA) and Ghent (Belgium), and is operated by a world class team of entrepreneurs, scientists and transatlantic network of investors, in concert with strategic research and development collaborations. The latter includes collaborations with VIB (Belgium), Orionis Biosciences co-founding institution.